Vaccine News and Research

Latest Vaccine News and Research

Recap of key briefing on advancements in malaria fight

This post in the Malaria Policy Center blog recaps a Tuesday Capitol Hill briefing, hosted by Senators Chris Coons (D-Del.) and Roger Wicker (R-Miss.), co-chairs of the Senate Working Group on Malaria, "that highlighted research and development advancements by the U.S. military and U.S. academic institutions to develop the tools to eliminate malaria and keep our servicemen and women safe as they serve overseas."

7 Oct 2011

Virginia Bioinformatics Institute releases upgraded ENISI software

Researchers with the Virginia Bioinformatics Institute at Virginia Tech have released an upgrade to the institute's ENteric Immunity SImulator (ENISI) software, which models immune responses to beneficial and harmful bacteria that enter the gastrointestinal tract of mice, pigs, and humans.

7 Oct 2011

The male circumcision debate continues

Much has been written on the controversies and debates on whether males – from infants to adults – have a human right to retain their foreskin. The protestors have helped persuade 18 states to stop paying for circumcisions under their Medicaid health insurance programs.

5 Oct 2011

HPV may be responsible for the alarming numbers of oral cancers: Study

Sore throat for a very long time could be an early precursor of a sexually transmitted virus that is fueling a rise in oral cancer suggest researchers. Between 1988 and 2004, head, neck and throat cancers that tested positive for the human papilloma virus rose an astounding 225 percent, according to a new study.

4 Oct 2011

Parents choosing alternative vaccine schedules for their kids: Survey

According to a new study some parents choose alternative schedules for vaccinating their children and yet others decide their own vaccine timelines.

4 Oct 2011

Dramatic rise in U.S. incidence of oropharyngeal cancer can be attributed to HPV infection

A new study of oropharyngeal cancer suggests that dramatic increases in U.S. incidence of the cancer and survival since 1984 can be attributed to infection with the human papillomavirus.

4 Oct 2011

DNA primer vaccine enhances immune response to H5N1 avian influenza vaccine

The immune response to an H5N1 avian influenza vaccine was greatly enhanced in healthy adults if they were first primed with a DNA vaccine expressing a gene for a key H5N1 protein, researchers say.

4 Oct 2011

Addressing high-risk groups, couples counseling in HIV prevention

In this post in the Center for Global Development's "Global Health Policy" blog, Mead Over, a senior fellow at the center, follows up on a post last week in which he wrote that a panel of senior economists commissioned by the Rush Foundation was to address the question of how to spend an additional, but hypothetical, $10 billion on HIV/AIDS programs in Africa over the next five years.

4 Oct 2011

Emergent BioSolutions receives $1.25B contract to supply 44.75M doses of BioThrax

Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.

3 Oct 2011

GeoVax completes enrollment for HIV/AIDS vaccine Phase 2a clinical trial

GeoVax Labs, Inc., an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced today the completion of enrollment for a Phase 2a clinical trial testing its HIV/AIDS vaccine.

3 Oct 2011

CSL pays heed to FDA observations on faulty manufacturing processes

Australia’s biggest pharmaceutical company CSL has taken steps to address most manufacturing flaws highlighted by the US Food and Drug Administration (FDA) and promised that the remaining concerns are being resolved.

2 Oct 2011

Researchers identify gene responsible for starting the biological clock

Ever wondered why you wake up in the morning ---- even when the alarm clock isn't making jarring noises? Wonder no more. Researchers at the Salk Institute for Biological Studies have identified a new component of the biological clock, a gene responsible for starting the clock from its restful state every morning.

1 Oct 2011

Dialysis patients with kidney failure more likely to develop serious complications from flu

For most people, the flu is a temporary setback that makes them feel under the weather for a week or two. For dialysis patients with kidney failure, however, the flu is a serious health threat that can lead to pneumonia and other life-threatening complications.

1 Oct 2011

Viewpoints: Sebelius on improving care; Samuelson on health costs; Durenberger on exporting U.S. system

Far too many Americans still go without the best care. That's why the Obama administration has joined with Truman Medical Centers and more than 2,500 other hospitals nationwide, along with thousands of employers, health insurers, provider organizations and patient advocates, to launch the Partnership for Patients … Over the next three years, we will reduce preventable injuries in hospitals by 40 percent. And we will cut hospital re-admissions by 20 percent, targeting the return trips that should never have occurred.

1 Oct 2011

Poll: 21.4% of Americans believe vaccines can cause autism

More than one-quarter of Americans are concerned about the value and safety of vaccines and 21.4 percent believe vaccines can cause autism, according to the Thomson Reuters-NPR Health Poll.

1 Oct 2011

Meeting with Bill Gates, Nigerian President Jonathan re-affirms country's commitment to eradicating polio within two years

In a meeting at the presidential villa on Thursday, Nigerian President Goodluck Jonathan told Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "that he was determined to eradicate polio within two years after the crippling disease re-emerged earlier this year," Agence France-Presse reports.

1 Oct 2011

Free radical peroyxnitrite linked to failure of cytotoxic T-cells to eliminate tumors

Researchers at the Moffitt Cancer Center in Tampa, Fla., and colleagues have found that tumor cell resistance to a specific cancer immunotherapy designed to kill cancer cells can be blamed on a mechanism that involves the production of a free radical peroxynitrite (PNT) that causes resistance to therapeutic cancer-killing cells.

30 Sep 2011

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Galectin Therapeutics Inc. today announced that it posted a new corporate presentation video to its website, www.galectintherapeutics.com, that highlights the Company's leadership position in developing galectin-inhibiting therapeutics to treat fibrosis and cancer.

30 Sep 2011

Several barriers to providing decent health care to poor people in developing countries

If you want to provide poor people in developing countries with decent health care, you need to overcome several barriers at the same time. That is the conclusion of researcher Bart Jacobs, based on years of research in Cambodia - and on his experience in several other low- and mid-income countries. The local community and existing social networks play an important role, but the authorities also have a role to play.

30 Sep 2011

Study highlights importance of prior planning before introduction of new vaccines

Proper planning before the introduction of new vaccines into a developing country's active immunization program could prevent storage problems and transportation bottlenecks that decrease the availability of existing vaccines by as much as two-thirds, according to a University of Pittsburgh study.

30 Sep 2011

Vaccine News and Research

Latest Vaccine News and Research

Recap of key briefing on advancements in malaria fight

Virginia Bioinformatics Institute releases upgraded ENISI software

The male circumcision debate continues

HPV may be responsible for the alarming numbers of oral cancers: Study

Parents choosing alternative vaccine schedules for their kids: Survey

Dramatic rise in U.S. incidence of oropharyngeal cancer can be attributed to HPV infection

DNA primer vaccine enhances immune response to H5N1 avian influenza vaccine

Addressing high-risk groups, couples counseling in HIV prevention

Emergent BioSolutions receives $1.25B contract to supply 44.75M doses of BioThrax

GeoVax completes enrollment for HIV/AIDS vaccine Phase 2a clinical trial

CSL pays heed to FDA observations on faulty manufacturing processes

Researchers identify gene responsible for starting the biological clock

Dialysis patients with kidney failure more likely to develop serious complications from flu

Viewpoints: Sebelius on improving care; Samuelson on health costs; Durenberger on exporting U.S. system

Poll: 21.4% of Americans believe vaccines can cause autism

Meeting with Bill Gates, Nigerian President Jonathan re-affirms country's commitment to eradicating polio within two years

Free radical peroyxnitrite linked to failure of cytotoxic T-cells to eliminate tumors

Galectin posts new corporate video on galectin-inhibiting therapeutics to treat fibrosis and cancer

Several barriers to providing decent health care to poor people in developing countries

Study highlights importance of prior planning before introduction of new vaccines

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Vaccine News and Research

Latest Vaccine News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in